Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: BMJ Qual Saf. 2020 Dec 22;30(7):599–607. doi: 10.1136/bmjqs-2020-011817

Table 2:

Characteristics of patients triaged in both groups.

TSS Triage RCS Triage
n=1787 n=793 Standardized differences
Mean (SD) / N (%)
Age (years) 52.1 (16.0) 52.5 (15.8) 0.03
Male (%) 1653 (92.5) 725 (91.4) 0.04
White (%) 1256 (70.3) 543 (68.5) 0.04
Hispanic (%) 118 (6.6) 58 (7.3) 0.03
BMI Category (%)
 <30 kg/m2 596 (33.4) 273 (34.4) 0.09
 30-34.9 kg/m2 497 (27.8) 193 (24.3)
 35-39.9 kg/m2 257 (14.4) 114 (14.4)
 ≥40 kg/m2 145 (8.1) 67 (8.4)
 Missing BMI 292 (16.3) 146 (18.4)
BMI (kg/m2)** 32.0 (6.2) 32.0 (6.5) 0.00
Hypertension (%) 647 (36.2) 265 (33.4) 0.06
Myocardial Infarction (%) 23 (1.3) 16 (2.0) 0.06
Congestive Heart Failure (%) 74 (4.1) 36 (4.5) 0.02
Stroke (%) 100 (5.6) 42 (5.3) 0.01
Chronic Lung Disease (%) 237 (13.3) 85 (10.7) 0.08
Sleep Disturbance NOS (%) 100 (5.6) 43 (5.4) 0.01
Restless Leg Syndrome (%) 16 (0.9) 7 (0.9) 0.00
Insomnia (%) 195 (10.9) 114 (14.4) 0.10
Atrial Fibrillation (%) 89 (5.0) 39 (4.9) 0.00
Any Opioid Rx (%) 91 (5.1) 36 (4.5) 0.03
Alpha Blocker Rx (%) 143 (8.0) 61 (7.7) 0.01
PDE-5 Inhibitor Rx (%) 22 (1.2) 7 (0.9) 0.03
Charlson Score (points) 1.9 (2.3) 1.9 (2.3) 0.02
Drive Time (minutes) 55.6 (34.2) 58.2 (34.1) 0.08

Legend: TSS-Traditional Specialist-Led System, RCS-Referral Coordination System, BMI-Body Mass Index Rx-Prescription.; NOS-Not Otherwise Specified, Rx-Prescription, PDE-5-Phosphodiesterase.